Latest news with #Theriot
Yahoo
6 days ago
- General
- Yahoo
Baton Rouge man accused of putting tracking device on woman's vehicle
BATON ROUGE, La. (Louisiana First) — An investigation by the East Baton Rouge Sheriff's Office (EBRSO) led to the discovery of a tracking device on a vehicle and landed one man in jail on multiple charges. Cory Theriot, 55, of Baton Rouge, was charged with one count of prohibited usage of tracking device(s), identity theft, unauthorized entry of an inhabited dwelling, and telephone communications; improper language; harassment. EBRSO started the investigation on the morning of May 23, 2025. Theriot is accused of illegally entering a home in an effort to reach a woman. According to the affidavit, the man allegedly continued to contact the victim excessively via social media and telephone. An arrest warrant was then issued for Theriot, EBRSO said. The woman took her vehicle to a dealership because Theriot appeared to know where she was earlier that day. An employee at the dealership 'found a stand-alone tracking device attached to the metal rear bumper cross support,' according to the affidavit. Police arrest man accused of March Baton Rouge shooting The victim stated that she did not give permission to put the tracking device on her vehicle. EBRSO was able to determine that Theriot was the owner of the account for the tracking device The Baton Rouge man was booked into the East Baton Rouge Parish Prison on Monday, June 2. Five arrested in Baton Rouge shooting that killed man on S. Harrell's Ferry Road Hot Wheels custom T-Bird blends 1967 muscle with pop art firepower Speaker Johnson: Trump 'not delighted' at Musk '180' on megabill Baton Rouge restaurants with steak on the menu for Father's Day Woman dies from brain-eating amoeba after using tap water to clear sinuses: CDC Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Reuters
31-01-2025
- Business
- Reuters
US government could seek over $1 billion from J&J for cancer treatment costs
NEW YORK, Jan 31 (Reuters) - The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson (JNJ.N), opens new tab as reimbursement for federal health agencies' payments of medical costs for patients who allege that the company's baby powder and other talc products caused them to develop cancer, a government attorney said Friday. HHS and the Department of Veterans Affairs recently objected to J&J's $10 billion proposed settlement of tens of thousands of ovarian cancer lawsuits, saying that resolving those cases in bankruptcy could impair the government's reimbursement rights. Bethany Theriot, a U.S. Justice Department attorney representing the two agencies, said that HHS alone could seek $1.1 billion under the Medicare Secondary Payer law, which allows federal health agencies to seek reimbursement from other parties that are primarily responsible for health care costs incurred by the government. "HHS and VA do have significant claims here, and we have serious objections to the ways in which the plan appears to potentially curtail federal rights,' Theriot said at a Friday bankruptcy court hearing in Houston. The HHS estimate is based on the number of people who have alleged that J&J products caused their cancer, and the government could seek additional reimbursements as more people develop cancer in the future, Theriot told U.S. Bankruptcy Judge Christopher Lopez, who is overseeing the bankruptcy of a J&J subsidiary. J&J, which has denied allegations that its baby powder or other talc products contained asbestos and caused cancer, did not immediately respond to a request for comment on Friday. J&J is attempting to resolve tens of thousands of lawsuits alleging that its talc products caused ovarian cancer through a $10 billion settlement that would resolve all current lawsuits and prevent new cases from being filed. J&J placed its subsidiary Red River Talc into bankruptcy on Sept. 20, 2024, in an attempt to finalize the settlement. Courts have rejected J&J's two previous efforts to resolve the talc litigation, ruling that J&J's subsidiary was not eligible for bankruptcy because it was not in "financial distress." J&J is trying again in a different bankruptcy court, and it says that the third effort can succeed where the others faltered because it now has votes showing a broad level of support for its settlement proposal. J&J's proposal is opposed by attorneys representing some cancer victims, insurers, and the Office of the U.S. Trustee, a Justice Department watchdog that promotes integrity and efficiency in U.S. bankruptcy proceedings. Cancer victims who oppose the bankruptcy said they should be allowed to resume their lawsuits instead of being forced to settle on J&J's terms. J&J said its proposed settlement is supported by more than 80% of the people who have filed talc lawsuits, and that settling the lawsuits in bankruptcy is faster and more equitable than continuing to fight the lawsuits one at a time. J&J will defend its bankruptcy plan in a multi-day court hearing scheduled to begin on Feb. 18. Lopez will consider competing demands to approve or reject the talc settlement. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Yahoo
31-01-2025
- Business
- Yahoo
US government could seek over $1 billion from J&J for cancer treatment costs
By Dietrich Knauth NEW YORK (Reuters) - The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as reimbursement for federal health agencies' payments of medical costs for patients who allege that the company's baby powder and other talc products caused them to develop cancer, a government attorney said Friday. HHS and the Department of Veterans Affairs recently objected to J&J's $10 billion proposed settlement of tens of thousands of ovarian cancer lawsuits, saying that resolving those cases in bankruptcy could impair the government's reimbursement rights. Bethany Theriot, a U.S. Justice Department attorney representing the two agencies, said that HHS alone could seek $1.1 billion under the Medicare Secondary Payer law, which allows federal health agencies to seek reimbursement from other parties that are primarily responsible for health care costs incurred by the government. "HHS and VA do have significant claims here, and we have serious objections to the ways in which the plan appears to potentially curtail federal rights,' Theriot said at a Friday bankruptcy court hearing in Houston. The HHS estimate is based on the number of people who have alleged that J&J products caused their cancer, and the government could seek additional reimbursements as more people develop cancer in the future, Theriot told U.S. Bankruptcy Judge Christopher Lopez, who is overseeing the bankruptcy of a J&J subsidiary. J&J, which has denied allegations that its baby powder or other talc products contained asbestos and caused cancer, did not immediately respond to a request for comment on Friday. J&J is attempting to resolve tens of thousands of lawsuits alleging that its talc products caused ovarian cancer through a $10 billion settlement that would resolve all current lawsuits and prevent new cases from being filed. J&J placed its subsidiary Red River Talc into bankruptcy on Sept. 20, 2024, in an attempt to finalize the settlement. Courts have rejected J&J's two previous efforts to resolve the talc litigation, ruling that J&J's subsidiary was not eligible for bankruptcy because it was not in "financial distress." J&J is trying again in a different bankruptcy court, and it says that the third effort can succeed where the others faltered because it now has votes showing a broad level of support for its settlement proposal. J&J's proposal is opposed by attorneys representing some cancer victims, insurers, and the Office of the U.S. Trustee, a Justice Department watchdog that promotes integrity and efficiency in U.S. bankruptcy proceedings. Cancer victims who oppose the bankruptcy said they should be allowed to resume their lawsuits instead of being forced to settle on J&J's terms. J&J said its proposed settlement is supported by more than 80% of the people who have filed talc lawsuits, and that settling the lawsuits in bankruptcy is faster and more equitable than continuing to fight the lawsuits one at a time. J&J will defend its bankruptcy plan in a multi-day court hearing scheduled to begin on Feb. 18. Lopez will consider competing demands to approve or reject the talc settlement. Sign in to access your portfolio
